The Core Challenge
The molecular sequencing streams at Novartis Diagnostics generated heavy sequential file packages. The baseline client interface used legacy server routing loops, creating massive queueing latency. During peak medical diagnostic phases, genomic sequence processes stalled, failing immediate treatment pipeline milestones. Novartis required an architecture capable of processing concurrent sequences under rigorous healthcare security standards.
Our Custom Engineering Approach
MBS Technologies designed a custom parallel ingestion engine. We decoupled the main network requests using managed private nodes with isolated S3 storage filters. All diagnostics are micro-split and triggered concurrently using optimized AWS serverless runtimes. Data transit is bound inside secure, hardware-isolated secure parameters to lock out public network exposures completely.
ARCHITECTURAL BLUEPRINT ACCENTS:
Decoupled execution boundaries using isolated event queues. Zero global calculations latency, automatic storage shards encryption scales dynamically with load spikes.
The Tactical Achievements
Upon deploying the parallel cloud pipeline, sequential analytical queues dropped instantly. The clinical network successfully handles real-time DNA sequences with complete security integrity, unlocking digital research scale for local centers.
Operational KPIs
3.5x Enhancement
Diagnostic matching clearance rates are 3.5 times faster.
100% HIPAA
End-to-end hardware encryption & key management audited.
99.999% Seamless
High availability cloud cluster guarantees perpetual online status.
CASE SUMMARY
- Client: Novartis Diagnostics
- Category: Cloud Engineering & DevOps
- Platforms: AWS Cloud, Node serverless
- Compliance: NIST, HIPAA certified